Pro Medicus (OTCMKTS:PMCUF) Shares Down 1.6% – Time to Sell?

Shares of Pro Medicus Limited (OTCMKTS:PMCUF) traded down 1.6% during trading on Thursday . The stock traded as low as $96.47 and last traded at $96.47. 50 shares were traded during mid-day trading, a decline of 92% from the average session volume of 624 shares. The stock had previously closed at $98.00.

Analysts Set New Price Targets

Separately, Jefferies Financial Group set a $155.00 price target on shares of Pro Medicus and gave the stock a “buy” rating in a research note on Thursday, February 12th. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat, Pro Medicus currently has a consensus rating of “Buy” and a consensus target price of $155.00.

Pro Medicus Stock Down 1.6%

The stock has a 50 day moving average of $90.38 and a two-hundred day moving average of $127.73.

Pro Medicus Company Profile

Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.

The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.